These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 15283772)
1. Transgenic mice for studies of the renin-angiotensin system in hypertension. Lavoie JL; Bianco RA; Sakai K; Keen HL; Ryan MJ; Sigmund CD Acta Physiol Scand; 2004 Aug; 181(4):571-7. PubMed ID: 15283772 [TBL] [Abstract][Full Text] [Related]
2. Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system. Fukamizu A; Takimoto E; Sugimura K; Hatae T; Seo MS; Takahashi S; Sugiyama F; Kajiwara N; Yagami K; Murakami K Arzneimittelforschung; 1993 Feb; 43(2A):222-5. PubMed ID: 8498968 [TBL] [Abstract][Full Text] [Related]
3. Genetic manipulation of the renin-angiotensin system: targeted expression of the renin-angiotensin system in the kidney. Sigmund CD Am J Hypertens; 2001 Jun; 14(6 Pt 2):33S-37S. PubMed ID: 11411763 [TBL] [Abstract][Full Text] [Related]
4. The kidney and hypertension: lessons from mouse models. Chen D; Coffman TM Can J Cardiol; 2012 May; 28(3):305-10. PubMed ID: 22482395 [TBL] [Abstract][Full Text] [Related]
6. Targeting genes in the renin-angiotensin system. Le TH; Coffman TM Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):57-63. PubMed ID: 18090671 [TBL] [Abstract][Full Text] [Related]
7. New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Cole JM; Xiao H; Adams JW; Disher KM; Zhao H; Bernstein KE Am J Physiol Renal Physiol; 2003 Apr; 284(4):F599-607. PubMed ID: 12620918 [TBL] [Abstract][Full Text] [Related]
8. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Lavoie JL; Lake-Bruse KD; Sigmund CD Am J Physiol Renal Physiol; 2004 May; 286(5):F965-71. PubMed ID: 15075192 [TBL] [Abstract][Full Text] [Related]
9. Central angiotensinergic mechanisms associated with hypertension. O'Callaghan EL; Choong YT; Jancovski N; Allen AM Auton Neurosci; 2013 Apr; 175(1-2):85-92. PubMed ID: 23466041 [TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. Grande MT; Pascual G; Riolobos AS; Clemente-Lorenzo M; Bardaji B; Barreiro L; Tornavaca O; Meseguer A; López-Novoa JM Free Radic Biol Med; 2011 Nov; 51(10):1831-41. PubMed ID: 21906672 [TBL] [Abstract][Full Text] [Related]
11. Genetic manipulation of the renin-angiotensin system in the kidney. Sigmund CD Acta Physiol Scand; 2001 Sep; 173(1):67-73. PubMed ID: 11678728 [TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841 [TBL] [Abstract][Full Text] [Related]
13. Understanding hypertension through genetic manipulation in mice. Cvetkovic B; Sigmund CD Kidney Int; 2000 Mar; 57(3):863-74. PubMed ID: 10720939 [TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure. Soldner A; Spahn-Langguth H; Mutschler E Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974 [TBL] [Abstract][Full Text] [Related]
15. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Mullins JJ; Peters J; Ganten D Nature; 1990 Apr; 344(6266):541-4. PubMed ID: 2181319 [TBL] [Abstract][Full Text] [Related]
16. Genetic targeting of the brain renin-angiotensin system in transgenic rats: impact on stress-induced renin release. Baltatu O; Campos LA; Bader M Acta Physiol Scand; 2004 Aug; 181(4):579-84. PubMed ID: 15283773 [TBL] [Abstract][Full Text] [Related]
17. Control of vascular tone by renin and angiotensin in cardiovascular disease. Brunner HR; Nussberger J; Waeber B Eur Heart J; 1993 Nov; 14 Suppl I():149-53. PubMed ID: 8293766 [TBL] [Abstract][Full Text] [Related]
18. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
19. Role of the renin-angiotensin-aldosterone system in collecting duct-derived endothelin-1 regulation of blood pressure. Ge Y; Huang Y; Kohan DE Can J Physiol Pharmacol; 2008 Jun; 86(6):329-36. PubMed ID: 18516095 [TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke). Laragh JH J Hum Hypertens; 1995 Jun; 9(6):385-90. PubMed ID: 7473515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]